Invasive ventilation in children during COVID-19 pandemic
Family-centered care in the PICU during the COVID-19 pandemic
The end of the pandemic
A comparison of five paediatric dosing guidelines for antibiotics
The bat, the pangolin and the city: a tale of COVID-19
Interim pharmacokinetic analysis of a multi-centre randomised open label phase IIb study in neonates to validate the meta-analysis population pharmacokinetic model used to simulate an optimised dosing regimen in neonates and infants aged < 90 days: the NeoVanc trial
An optimised dosing regimen vs. a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in infants less than 90 days: the NeoVanc trial
Respiratory pathogens detected in children with community-acquired sepsis-like syndrome in 6 European countries
Aetiology and outcome of children hospitalised for acute respiratory tract infections in Europe: findings from a multi-country combined case-control and cohort study
Application of WISCA (Weighted Incidence Syndromic Combination Antibiogram) to guide empiric therapy in oncological paediatric patients with febrile neutropenia
Antibiotic treatment for paediatric outpatients with community-acquired pneumonia: findings from 10 years of prescribing habits in Italy
Ethics in PIC in the time of COVID
Prof. Sarah Walker leads the CIS study on COVID-19
Overview on COVID-19 outbreak
Tribute to Lynda Harper
RECOVER enrolls first patients in its COVID-19 studies!